NMRD vs. AFIB, SONX, UTRS, MOTS, VIVE, DRTSW, ANZUW, ATAKW, BBLGW, and HSCSW
Should you be buying Nemaura Medical stock or one of its competitors? The main competitors of Nemaura Medical include Acutus Medical (AFIB), Sonendo (SONX), Minerva Surgical (UTRS), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), and Heart Test Laboratories (HSCSW). These companies are all part of the "medical equipment" industry.
Nemaura Medical vs. Its Competitors
Acutus Medical (NASDAQ:AFIB) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings.
In the previous week, Acutus Medical had 1 more articles in the media than Nemaura Medical. MarketBeat recorded 1 mentions for Acutus Medical and 0 mentions for Nemaura Medical. Acutus Medical's average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score.
Nemaura Medical has lower revenue, but higher earnings than Acutus Medical.
Nemaura Medical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Nemaura Medical's return on equity of 0.00% beat Acutus Medical's return on equity.
56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 4.4% of Nemaura Medical shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Comparatively, 40.4% of Nemaura Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Acutus Medical has a beta of -0.62, meaning that its share price is 162% less volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500.
Summary
Nemaura Medical beats Acutus Medical on 6 of the 9 factors compared between the two stocks.
Get Nemaura Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NMRD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nemaura Medical Competitors List
Related Companies and Tools
This page (NASDAQ:NMRD) was last updated on 8/22/2025 by MarketBeat.com Staff
MarketBeat All Access